These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31235241)

  • 1. Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery.
    Kranawetter M; Ataseven B; Grimm C; Schneider S; Riss S; Alesina P; Prader S; Walz MK; Harpain F; Stift A; Heitz F; Reinthaller A; Polterauer S; Harter P; du Bois A
    Gynecol Oncol; 2019 Sep; 154(3):577-582. PubMed ID: 31235241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low anterior resection syndrome (LARS) in ovarian cancer patients - A multi-centre comparative cohort study.
    Harpain F; Kranawetter M; Zott T; Lazaridis II; Guenin MO; Ninkovic M; Kronberger IE; Tapiolas I; Basany EE; Dauser B; Herbst F; Koh C; Stift A; Teleky B; Reinthaller A; Grimm C; Riss S
    Int J Surg; 2020 Jun; 78():97-102. PubMed ID: 32304899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer.
    Bartl T; Schwameis R; Stift A; Bachleitner-Hofmann T; Reinthaller A; Grimm C; Polterauer S
    Int J Gynecol Cancer; 2018 Nov; 28(9):1664-1671. PubMed ID: 30371563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
    Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
    Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal study.
    Imterat M; Gebers G; Heitz F; Schneider S; Ehmann S; Welz J; du Bois A; Traut A; Walz MK; Concin N; Harter P; Ataseven B
    Gynecol Oncol; 2023 Nov; 178():96-101. PubMed ID: 37839314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary debulking surgery vs. interval debulking surgery for advanced ovarian cancer: review of the literature and meta-analysis.
    Chiofalo B; Bruni S; Certelli C; Sperduti I; Baiocco E; Vizza E
    Minerva Med; 2019 Aug; 110(4):330-340. PubMed ID: 31081304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive validity of American College of Surgeons: National Surgical Quality Improvement Project risk calculator in patients with ovarian cancer undergoing interval debulking surgery.
    Manning-Geist B; Cathcart AM; Sullivan MW; Pelletier A; Cham S; Muto MG; Del Carmen M; Growdon WB; Sisodia RC; Berkowitz R; Worley M
    Int J Gynecol Cancer; 2021 Oct; 31(10):1356-1362. PubMed ID: 34518239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.
    Suidan RS; Leitao MM; Zivanovic O; Gardner GJ; Long Roche KC; Sonoda Y; Levine DA; Jewell EL; Brown CL; Abu-Rustum NR; Charlson ME; Chi DS
    Gynecol Oncol; 2015 Aug; 138(2):246-51. PubMed ID: 26037900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National trends in bowel and upper abdominal procedures in ovarian cancer surgery.
    Dottino JA; He W; Sun CC; Zhao H; Fu S; Rauh-Hain JA; Suidan RS; Lu KH; Giordano SH; Meyer LA
    Int J Gynecol Cancer; 2020 Aug; 30(8):1195-1202. PubMed ID: 32616627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hospital surgical volume on complete gross resection (CGR) rates following primary debulking surgery for advanced stage epithelial ovarian carcinoma.
    Nasioudis D; Kahn R; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
    Gynecol Oncol; 2019 Aug; 154(2):401-404. PubMed ID: 31160074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of morbidity associated with pancreatic resection during cytoreductive surgery for epithelial ovarian cancer: A systematic review.
    Di Donato V; Bardhi E; Tramontano L; Capomacchia FM; Palaia I; Perniola G; Plotti F; Angioli R; Giancotti A; Muzii L; Panici PB
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):694-702. PubMed ID: 31806515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgery.
    Grimm C; Harter P; Alesina PF; Prader S; Schneider S; Ataseven B; Meier B; Brunkhorst V; Hinrichs J; Kurzeder C; Heitz F; Kahl A; Traut A; Groeben HT; Walz M; du Bois A
    Gynecol Oncol; 2017 Sep; 146(3):498-503. PubMed ID: 28610745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer.
    Saitou M; Iida Y; Komazaki H; Narui C; Matsuno K; Kawabata A; Ueda K; Tanabe H; Takakura S; Isonishi S; Sasaki H; Okamoto A
    Arch Gynecol Obstet; 2015 Mar; 291(3):641-6. PubMed ID: 25182215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events.
    Straubhar AM; Wolf JL; Zhou MQC; Iasonos A; Cham S; Wright JD; Long Roche K; Chi DS; Zivanovic O
    Gynecol Oncol; 2021 Feb; 160(2):438-444. PubMed ID: 33272645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications and Survivorship Trends After Primary Debulking Surgery for Ovarian Cancer.
    Xu Z; Becerra AZ; Justiniano CF; Aquina CT; Fleming FJ; Boscoe FP; Schymura MJ; Sinno AK; Chaoul J; Morrow GR; Minasian L; Temkin SM
    J Surg Res; 2020 Feb; 246():34-41. PubMed ID: 31561176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
    Xu Y; Jia Y; Zhang Q; Du Y; He Y; Zheng A
    Gynecol Oncol; 2021 Feb; 160(2):610-618. PubMed ID: 33221022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Risk Factors of Low Anterior Resection Syndrome in Epithelial Ovarian Cancer Surgery.
    Yasin I; Saeed Usmani A; Mohsin J; Asif RB; Kahlid N; Syed AA
    Cureus; 2022 Mar; 14(3):e23180. PubMed ID: 35444906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical outcomes of diaphragmatic resection during cytoreductive surgery for advanced gynecological ovarian neoplasia: A randomized single center clinical trial - DRAGON.
    Cianci S; Fedele C; Vizzielli G; Pasciuto T; Gueli Alletti S; Cosentino F; Chiantera V; Fagotti A; Scambia G
    Gynecol Oncol; 2022 Feb; 164(2):271-277. PubMed ID: 34844774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity of multiple bowel resection compared to single bowel resection after debulking surgery for ovarian cancer.
    Tozzi R; Casarin J; Baysal A; Pinelli C; Matak L; Ghanbarzadeh N; Alazzam M; Garruto-Campanile R; Majd HS; Kilic Y; Morotti M
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():215-219. PubMed ID: 31326636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.